See more : Avicopter Plc (600038.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Integrated Diagnostics Holdings plc (IDHC.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Integrated Diagnostics Holdings plc, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Sancus Lending Group Limited (LEND.L) Income Statement Analysis – Financial Results
- Yuzhou Group Holdings Company Limited (YUZHF) Income Statement Analysis – Financial Results
- Alps Industries Limited (ALPSINDUS.BO) Income Statement Analysis – Financial Results
- Grupo Famsa, S.A.B. de C.V. (GFAMSAA.MX) Income Statement Analysis – Financial Results
- Rigel Resource Acquisition Corp. (RRAC-WT) Income Statement Analysis – Financial Results
Integrated Diagnostics Holdings plc (IDHC.L)
About Integrated Diagnostics Holdings plc
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 30, 2021, it operated a network of 452 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.12B | 3.61B | 5.22B | 2.66B | 2.23B | 1.92B | 1.51B | 1.17B | 1.01B | 860.23M | 671.58M | 641.60M |
Cost of Revenue | 2.60B | 2.14B | 2.42B | 1.31B | 1.14B | 973.07M | 784.70M | 542.69M | 467.53M | 479.51M | 442.02M | 406.66M |
Gross Profit | 1.52B | 1.46B | 2.80B | 1.34B | 1.08B | 948.38M | 729.56M | 627.93M | 547.32M | 380.72M | 229.57M | 234.93M |
Gross Profit Ratio | 36.98% | 40.56% | 53.67% | 50.54% | 48.68% | 49.36% | 48.18% | 53.64% | 53.93% | 44.26% | 34.18% | 36.62% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 256.07M | 201.72M | 198.88M | 221.87M | 189.47M | 160.06M | 126.52M | 105.39M | 210.42M | 23.01M | 8.88M | 131.31M |
Selling & Marketing | 145.33M | 157.66M | 117.91M | 107.22M | 115.76M | 94.89M | 59.84M | 53.19M | 53.69M | 41.63M | 32.81M | 23.58M |
SG&A | 401.39M | 359.38M | 316.78M | 329.09M | 305.23M | 254.94M | 186.36M | 158.58M | 264.11M | 64.65M | 41.68M | 154.89M |
Other Expenses | 385.19M | 218.32M | 200.57M | -14.19M | -20.90M | -1.14M | -2.83M | -3.17M | -15.75M | 63.42M | 47.65M | 0.00 |
Operating Expenses | 786.59M | 577.70M | 517.35M | 314.90M | 284.33M | 253.80M | 186.36M | 158.58M | 264.11M | 128.07M | 89.33M | 150.24M |
Cost & Expenses | 3.38B | 2.72B | 2.94B | 1.63B | 1.43B | 1.23B | 971.06M | 701.26M | 731.63M | 607.58M | 531.34M | 556.90M |
Interest Income | 53.48M | 95.37M | 113.18M | 53.12M | 43.58M | 59.31M | 51.06M | 21.42M | 9.93M | 5.96M | 4.63M | 3.52M |
Interest Expense | 141.69M | 122.68M | 98.00M | 67.85M | 61.00M | 11.86M | 10.39M | 9.27M | 5.73M | 394.79K | 292.56K | 0.00 |
Depreciation & Amortization | 401.24M | 317.34M | 238.64M | 185.36M | 153.48M | 77.39M | 61.92M | 44.73M | 36.19M | 115.59M | 145.08M | 132.49M |
EBITDA | 1.28B | 1.29B | 2.57B | 1.22B | 972.62M | 806.60M | 630.74M | 442.54M | 316.41M | 366.55M | 280.90M | 198.33M |
EBITDA Ratio | 31.06% | 41.30% | 49.64% | 47.60% | 44.07% | 42.48% | 41.65% | 37.80% | 31.18% | 42.48% | 43.36% | 30.91% |
Operating Income | 737.76M | 1.17B | 2.26B | 985.55M | 790.84M | 684.94M | 540.37M | 466.19M | 267.46M | 245.09M | 133.13M | 65.84M |
Operating Income Ratio | 17.90% | 32.49% | 43.30% | 37.10% | 35.52% | 35.65% | 35.69% | 39.82% | 26.35% | 28.49% | 19.82% | 10.26% |
Total Other Income/Expenses | -406.00K | -317.80M | -29.74M | -16.46M | -32.70M | 32.42M | 18.06M | -77.65M | 7.03M | -3.21M | 6.11M | 22.38M |
Income Before Tax | 737.36M | 853.65M | 2.23B | 969.08M | 758.14M | 717.36M | 558.43M | 388.54M | 274.49M | 241.89M | 139.25M | 88.21M |
Income Before Tax Ratio | 17.89% | 23.68% | 42.73% | 36.48% | 34.05% | 37.33% | 36.88% | 33.19% | 27.05% | 28.12% | 20.73% | 13.75% |
Income Tax Expense | 268.99M | 327.06M | 739.82M | 359.60M | 253.61M | 220.44M | 174.70M | 121.62M | 119.52M | 100.20M | 70.46M | 59.24M |
Net Income | 510.30M | 541.11M | 1.41B | 594.02M | 510.93M | 502.09M | 374.02M | 260.40M | 144.87M | 132.77M | 62.10M | 24.64M |
Net Income Ratio | 12.38% | 15.01% | 27.04% | 22.36% | 22.95% | 26.13% | 24.70% | 22.24% | 14.28% | 15.43% | 9.25% | 3.84% |
EPS | 0.85 | 0.90 | 2.35 | 0.99 | 0.85 | 0.84 | 0.62 | 0.44 | 0.24 | 0.22 | 0.10 | 0.04 |
EPS Diluted | 0.85 | 0.90 | 2.35 | 0.99 | 0.85 | 0.84 | 0.62 | 0.44 | 0.24 | 0.22 | 0.10 | 0.04 |
Weighted Avg Shares Out | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M | 600.01M |
Weighted Avg Shares Out (Dil) | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M | 600.00M |
Source: https://incomestatements.info
Category: Stock Reports